sur Jaguar Health, Inc. (NASDAQ:JAGX)
Jaguar Health to Host Investor Webcast on November 17, 2025
Jaguar Health, Inc. has announced an investor webcast scheduled for Monday, November 17, 2025, at 8:30 a.m. Eastern Time. The webcast will address Jaguar's third-quarter 2025 financial performance and offer corporate updates. The announcement follows the company's plan to file its Earnings Report on November 14, 2025, concerning the quarter that ended on September 30, 2025.
Jaguar Health specializes in developing proprietary, plant-based prescription medicines targeting gastrointestinal issues. The company's family includes Napo Pharmaceuticals, focusing on supportive care for neglected gastrointestinal symptoms, and Napo Therapeutics, which aims to increase access to crofelemer in Europe. Additionally, Jaguar's efforts include a joint venture with Magdalena Biosciences targeting plant-derived mental health treatments.
R. P.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Jaguar Health, Inc.